Related Experiment Video
Updated: Aug 10, 2026
08:50
5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Vitamin D-induced hypercalcemia in experimental renal failure
Nephron
|January 1, 1977
Summary
Uremic rats developed greater hypercalcemia with vitamin D due to impaired renal calcium excretion and selective cortical bone resorption. Trabecular bone remained resistant in renal failure.
Area of Science:
- Nephrology
- Endocrinology
- Bone Biology
Background:
- Hypercalcemia is a common complication in chronic kidney disease.
- Vitamin D toxicity can exacerbate hypercalcemia, particularly in impaired renal function.
Purpose of the Study:
- To investigate the mechanisms of hypercalcemia in uremic rats treated with pharmacologic vitamin D.
- To compare bone resorption patterns and calcium handling in uremic versus non-uremic rats.
Main Methods:
- Induction of hypercalcemia in 5/6 nephrectomized rats and sham-operated controls using vitamin D.
- Analysis of bone resorption distribution (cortical vs. metaphyseal).
- Ultrastructural examination of thyroid C cells and measurement of urinary calcium excretion.
Main Results:
- Uremic rats exhibited greater hypercalcemia than controls when given vitamin D.
- Bone resorption was prominent in both groups but localized to diaphyseal cortical bone in uremic rats.
- Thyroid C cells were degranulated in both vitamin D-treated groups.
- Renal calcium excretion was reduced in uremic rats, leading to increased calcium retention.
Conclusions:
- Pharmacologic vitamin D induces significant hypercalcemia in uremic rats.
- Hypercalcemia in renal failure is driven by impaired renal calcium excretion and selective cortical bone resorption.
- Trabecular bone shows resistance to vitamin D effects in the context of renal failure.
Related Concept Videos
01:23Role of Skin in Vitamin D Synthesis
The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
01:21Skeleton and Calcium Homeostasis
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:20Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...